Key result
Baroreflex activation therapy is a promising treatment for drug-resistant hypertension, though further clarification is needed before its addition to common treatment guidelines.
Why the study?
Does electrical activation of the carotid sinus baroreflex improve outcomes in patients with drug-resistant hypertension?
Does electrical activation of the carotid sinus baroreflex improve outcomes in patients with drug-resistant hypertension?
Baroreflex activation therapy is a promising treatment for drug-resistant hypertension, though further clarification is needed before guideline inclusion.
Uncontrolled or resistant hypertension is still a major problem facing many physicians daily in the clinic. Several new therapies are being developed to help those patients whose blood pressure does not respond sufficiently to regular antihypertensive medication. One of these promising therapies is electrical activation of the carotid sinus baroreflex. In this overview, the authors predominantly summarize the background, efficacy and safety of this promising treatment with its latest achievements in patients with resistant hypertension. The authors also discuss certain issues that need further clarification before this therapy can be added to the common treatment guidelines of hypertension.
No takes yet. Share an insight, caveat, or question.
Alnima et al. (2014) conducted a review in Drug-resistant hypertension. Baroreflex activation therapy was evaluated. Baroreflex activation therapy is a promising treatment for drug-resistant hypertension, though further clarification is needed before its addition to common treatment guidelines.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: